Effects of interferon-β on microglial functions as inflammatory and antigen presenting cells in the central nervous system

Neuropharmacology

Volumn 46, Issue 5, 2004, Pages 734-742

  Kawanokuchi, Jun ^a   Mizuno, Tetsuya ^a   Kato, Hideki ^a   Mitsuma, Norimasa ^a   Suzumura, Akio ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Antigen presentation; Interferon ; Interleukin 12; Microglia; Multiple Sclerosis

Indexed keywords

B7 ANTIGEN; BETA INTERFERON; IBUDILAST; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DIFFERENTIATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EFFECTOR CELL; HELPER CELL; HUMAN; INFLAMMATORY CELL; MEDIATOR; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NEWBORN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIDE EFFECT; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; INFLAMMATION; INTERFERON-BETA; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA; MULTIPLE SCLEROSIS; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1442348871     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2003.11.007     Document Type: Article

References (52)

1. Abu-Khabar K.S., Armstrong J.A., Ho M. Type I interferons (IFN-α and -β) suppress cytotoxin (tumor necrosis factor-a and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cells. J. Leukocyte Biol. 52:1992;165-172.
2. Chabot S., Williams G., Yong V.W. Microglial production of TNF-α is induced by activated T lymphocytes; involvement of VLA-4 and inhibition by interferonβ-b. J. Clin. Invest. 100:1997;604-612.
3. Dasgupta S., Jana M., Liu X., Pahan K. Myelin basic protein-primed T cells induce nitric oxide synthase in microglial cells. J. Biol. Chem. 277:2002;39327-39333.
4. Dayal A.S., Jensen B.S., Liedo A., Arnason B.G.W. Interferon-gamma- secreting cells in multiple sclerosis patients treated with interferon beta-1b. Neurology. 45:1995;2173-2177.
5. Ewing C., Bernard C.C.A. Insights into the aetiology and pathogenesis of multiple sclerosis. Immunol. Cell. Biol. 76:1998;47-54.
6. Farrar J.D., Murphy K.M. Type I interferons and T helper development. Immunol. Today. 21:2000;486-489.
7. Fujimoto T., Sakoda S., Fujimura H., Yanagihara T. Ibudilast, a phosphodiesterase inhibitor, ameliorates experimental autoimmune encephalomyelitis in Dark August rats. J. Neuroimmunol. 95:(1-2):1999;35-42.
8. Gayo A., Mos L., Suarez A., et al. Interferon beta-1b treatment modulates TNFα and IFNγ spontaneous gene expression in MS. Neurology. 52:1999;1764-1770.
9. Guathikonda P., Baker J., Mattson D.H. Interferon-beta-1-b (IFN-β) decreases induced nitric oxide (NO) production by a human astrocytoma cell line. J. Neuroimmunol. 82:1998;133-139.
10. Hall G.L., Wing M.G., Compston D.A., Scolding N.J. β-Interferon regulates the immunomodulatory activity of neonatal rodent microglia. J. Neuroimmunol. 72:1997;11-19.
11. Hasko G., Szabo C., Nemeth Z.H., Deitch E.A. Sulphasalazine inhibits macrophage activation; inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression. Immunol. 103:2001;473-478.
12. Hersh E.M., Metch B.S., Muggia F.M., et al. Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience. J. Immunother. 10:1991;426-431.
13. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 239:(4837):1988;290-292.
14. Horley K.J., Carpenito C., Baker B., Takei F. Molecular cloning of murine intracellular adhesion molecule (ICAM-1). EMBO J. 8:1989;2889-2896.
15. Inaba K., Kitaura M., Kato T., et al. Contrasting effects of α-, β- and γ-interferon on expression of macrophage Ia antigens. J. Exp. Med. 163:1986;1030-1035.
16. Jiang H., Milo R., Swoveland P., et al. Interferon β-1b reduces interferon γ-induced antigen presenting capacity of human glial and B cells. J. Neuroimmunol. 61:1995;17-25.
17. Jimenez J.L., Punzon C., Navarro J., et al. Phosphodiesterase 4 inhibitors prevent cytokine secretion by lymphocytes by inhibiting nuclear factor-kappa B and nuclear factor of activated T cells activation. J. Pharmacol. Exp. Ther. 299:2001;753-759.
18. Joseph J., Knobler R.L., D'Imperio C., Lublin F.D. Downregulation of interferon-γ induced class II expression on human glioma cell by recombinant interferon-b: effects of dosage treatment schedule. J. Neuroimmunol. 20:1988;39-44.
19. Kambayashi T., Wallin R.P.I., Ljunggren H.G. cAMP-elebating agents suppress dendritic cell function. J. Leukoc. Biol. 70:2001;903-910.
20. Kapur S., Marcotte B., Marette A. Mechanism of adipose tissue iNOS induction in endotoxemia. Am. J. Physiol. 276:1999;E635-E641.
21. Killestein J., Hintzen R.Q., Uitdehaag B.M., et al. Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-beta. J. Neuroimmunol. 133:2002;217-224.
22. Kim M.O., Si Q., Zhou J.N., Pestell R.G., et al. Interferon-beta activates multiple signaling cascades in primary human microglia. J. Neurochem. 81:2002;1361-1371.
23. Klinkert W.E., Kojima K., Lesslauer W., et al. TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72:1997;163-168.
24. The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. 1999. TNF neutralization in MS: results of a placebo-controlled multicenter study. Neurology. 53, 457-465.
25. Martinez I., Puerta C., Redondo C., Garcia-Merino A. Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase. J. Neurol. Sci. 164:1999;13-23.
26. Menendez Iglesias B., Cerase J., Ceracchini C., Levi G., Aloisi F. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents. J. Neuroimmunol. 72:1997;83-93.
27. Merrill J., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
28. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 205:1994;1907-1915.
29. van Oosten B.W., Barkhof F., Fruyen L., et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology. 47:1996;1531-1534.
30. Ossege L.M., Sindern E., Voss B., Malin J.P. Immunomodulatory effects of IFNβ-1b on the mRNA-expression of TGFβ-1 and TNFα in vitro. Immunopharmacol. 43:1999;39-46.
31. Ozawa H., Aiba S., Nakagawa, Tagami H. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur. J. Immunol. 26:1996;648-652.
32. Park E., Schuller-Levis G., Park S.Y., Jia J.H., Levis W.R. Pentoxifylline downregulates nitric oxide and tumor necrosis factor-alpha induced by mycobacterial lipoarabinomannan in a macrophage cell line. Int. J. Lepr. Other Mycobact. Dis. 69:2001;225-233.
33. Rudick R.A., Ransofoff R.M., Peppler R., et al. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol. 40:1996;618-627.
34. Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:1989;394-397.
35. Sawada M., Suzumura A., Hosoya H., Marunouchi T., et al. IL-10 inhibits both production of cytokine and expression of cytokine receptors in microglia. J. Neurochem. 72:1999;1466-1471.
36. Sarchielli P., Critelli A., Greco L., et al. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A. Cytokine. 14:2001;294-298.
37. Satoh J., Lee Y.B., Kim S.U. T-cell costimulatory molecules B71 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res. 704:1995;92-96.
38. Selmaj K.W., Raine C.S., Farooq M. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147:1991;1522-1529.
39. Selmaj K., Raine C.S., Cannella B., Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87:1991;949-954.
40. Selmaj K.W., Raine C.S. Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology. 45:(suppl. 6):1995;S44-S49.
41. van Seventer J.M., Nagai T., van Seventer G.A. Interferon-β differentially regulates expression of the IL12 family members p35, p40, p19 and EB13 in activated human dendritic cells. J. Neuroimmunol. 133:2002;60-71.
42. Suzumura A., Sawada M. Microglia as immunoregulatory cells in the central nervous system. Eng E.A., et al. Topical Issues in Microglia Research. 1996;189-202 Singapore Neuroscience Association, Singapore.
43. Suzumura A., Mezitis S.G.E., Gonatas N., Silberberg D.H. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. J. Neuroimmunol. 15:1987;263-278.
44. Suzumura A., Sawada M., Takayanagi T. Production of interleukin-12 and the expression of its receptors by murine microglia. Brain Res. 787:1998;139-142.
45. Suzumura A., Sawada M. Effects of vesnarinone on activation of murine microglia. Life Science. 64:1999;1197-1203.
46. Suzumura A., Ito A., Yoshikawa M., Sawada M. Ibudilast suppresses TNFα production by glial cells functioning mainly as Type III phosphodiesterase inhibitor in the CNS. Brain Res. 837:1999;203-212.
47. Suzumura, A., Ito, A., Mizuno, T., 2003. Phosphodiesterase inhibitors suppress IL-12 production with microglia and T helper 1 development. Multiple Scler. 9, 574-578.
48. Suzumura A., Nakamuro T., Tamaru T., Takayanagi T. Drop in relapse rate of multiple sclerosis patients using combination therapy of three different phosphodiesterase inhibitors. Multiple Scler. 6:2000;56-58.
49. Weber F., Polak T., Gunther A., et al. Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis. Ann. Neurol. 44:1998;27-34.
50. Yong V.W., Chabot S., Stuve O., Williams G. Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology. 51:1998;682-689.
51. Yoshikawa M., Suzumura A., Tamaru T., et al. Effects of phosphodiesterase inhibitors on microglia. Multiple Scler. 5:1999;126-133.
52. Zhang B., Yang L., Konishi Y., Maeda N., Sakanaka M., Tanaka J. Suppressive effects of phosphodiesterase type IV inhibitors on rat cultured microglial cells: comparison with other types of cAMP-elevating agents. Neuropharmacology. 42:2002;262-269.